作为肉毒素活性位点抑制剂的thiosemicarbazides的调查:酶,细胞和动物中毒研究研究
Ealin N Patel1, Lucy Lin1, Hyeri Park1
1Department of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute of Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.
强有力的化剂提奥西米卡巴被研究为毒神经毒素A型 (BoNT/A) 轻链的抑制剂. 化合物ZMC1及其类似物显示出显著的BoNT/A抑制,在小鼠致死性试验中延长了生存期.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 药用化学 医学化学
背景情况:
- 甲型玻尿酸神经毒素 (BoNT/A) 是一种强大的神经毒素,具有治疗应用和生物武器潜力.
- BoNT/A 作为一种依赖的蛋白酶,分裂 SNARE 蛋白质以诱导.
研究的目的:
- 开发针对BoNT/A光链 (LC) 的新型抑制剂.
- 为了探索 thiosemicarbazones 为BoNT/A LC 抑制剂的支架,由于它们的切拉性质.
主要方法:
- 生物化学和动力学测试被用来评估抑制剂的疗效.
- 基于结构的分析指导了 thiosemicarbazone 类似物的设计和合成.
- 采用了酶活性,基于细胞的测定和BoNT/A小鼠致死性测定.
主要成果:
- 提奥西米卡巴ZMC1被确定为BoNT/A LC的竞争性抑制剂.
- 两种合成的西奥塞米卡巴类似物显示出显著的细胞活性.
- 在体内抑制BoNT/A导致小鼠在统计学上显著的延长生存期.
结论:
- 西米卡巴是开发BoNT/ALC抑制剂的一类有前途的化合物.
- 针对BoNT/A的依赖的蛋白酶活性提供了一个可行的治疗策略.
- 开发的抑制剂显示出对抗BoNT/A毒性的潜力.
更多相关视频
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
